[{"Assets_0_Q3_USD":7514553000.0,"CommonStockSharesOutstanding_0_Q3_shares":257265000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":1123322000.0,"NetIncomeLoss_1_Q3_USD":57518000.0,"NetIncomeLoss_3_Q3_USD":593576000.0,"EarningsPerShareBasic_1_Q3_USD":0.22,"EarningsPerShareBasic_3_Q3_USD":2.32,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":256946000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":256289000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20191031"}]